Samrat Pharmachem Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

137.22

157.62

115.50

106.31

76.76

Operating profit

1.00

21.14

18.77

5.58

4.28

Interest

0.35

0.46

0.29

0.38

0.74

Gross profit

1.31

20.86

18.80

5.42

3.58

EPS (Rs)

1.37

49.45

43.50

12.12

7.24

Other income

0.66

0.18

0.33

0.23

0.04

Stock adjustment

4.17

-12.35

-0.85

0.52

3.31

Raw material

127.76

144.42

93.14

97.10

66.72

Power and fuel

-

-

-

-

-

Employee expenses

1.00

0.84

1.00

0.78

0.58

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

3.29

3.57

3.45

2.35

1.87

Provisions made

-

-

-

-

-

Depreciation

0.33

0.32

0.30

0.29

0.23

Taxation

0.57

5.27

5.03

1.39

1.11

Net profit / loss

0.42

15.28

13.44

3.74

2.24

Extra ordinary item

-

-

-0.02

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

3.09

3.09

3.09

3.09

3.09

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

0.73

13.41

16.25

5.25

5.57

GPM (%)

.95

13.22

16.23

5.09

4.66

NPM (%)

0.31

9.68

11.61

3.51

2.91